Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.
Infect Immun
; 86(2)2018 02.
Article
em En
| MEDLINE
| ID: mdl-29203540
ABSTRACT
Clinical trials of novel tuberculosis (TB) vaccines are expensive, while global resources for TB vaccine development are limited. Therefore, there is a need for robust and predictive preclinical data to support advancement of candidate vaccines into clinical trials. Here, we provide a rationale for using the nonhuman primate as an essential component of these efforts, as well as guidance to the TB community for standardizing experimental design and aligning endpoints to facilitate development of new TB vaccines.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tuberculose
/
Vacinas contra a Tuberculose
/
Modelos Animais de Doenças
/
Avaliação Pré-Clínica de Medicamentos
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Animals
Idioma:
En
Revista:
Infect Immun
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Estados Unidos